Quick answer
Everest Group, Ltd. (EG) reported revenue of $17.50B and net income of $1.59B for the fiscal year ended 2025-12-31, up 1.2% from $17.28B the year before, per its 10-K filed with the SEC on 2026-02-26.
Data as of 2025-12-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Fiscal year | Revenue | Net income | Long-term debt |
|---|---|---|---|
| 2025 (FY ending 2025-12-31) | $17.50B | $1.59B | — |
| 2024 (FY ending 2024-12-31) | $17.28B | $1.37B | — |
| 2023 (FY ending 2023-12-31) | $14.59B | $2.52B | — |
| 2022 (FY ending 2022-12-31) | $12.06B | $597.0M | — |
| 2021 (FY ending 2021-12-31) | $11.87B | $1.38B | — |
| 2020 (FY ending 2020-12-31) | $9.60B | — | — |
| 2019 (FY ending 2019-12-31) | $8.23B | — | — |
| 2018 (FY ending 2018-12-31) | $7.36B | — | — |
| 2017 (FY ending 2017-12-31) | $6.62B | — | — |
| 2016 (FY ending 2016-12-31) | $5.79B | — | — |
Related
- ECL revenue, net income and debt history (Ecolab Inc.)
- ED revenue, net income and debt history (Consolidated Edison Inc)
- EFX revenue, net income and debt history (Equifax Inc)
- EHC revenue, net income and debt history (Encompass Health Corporation)
- EIX revenue, net income and debt history (Edison International)
- ELAN revenue, net income and debt history (Elanco Animal Health Incorporated)
- ELS revenue, net income and debt history (Equity Lifestyle Properties, Inc.)
- ELV revenue, net income and debt history (Elevance Health, Inc.)
Last updated 2026-10-16. Data only, not financial or tax advice.